{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T06:55:31Z","timestamp":1793429731418,"version":"4.5.0"},"reference-count":108,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:00:00Z","timestamp":1760400000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:00:00Z","timestamp":1760400000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key R&D Program of China","doi-asserted-by":"crossref","award":["2024YFC2309700"],"award-info":[{"award-number":["2024YFC2309700"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Nature Science Foundation of China","award":["82430075"],"award-info":[{"award-number":["82430075"]}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20240519"],"award-info":[{"award-number":["BK20240519"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273755"],"award-info":[{"award-number":["82273755"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Dis Poverty"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Schistosomiasis, an infectious disease of poverty, remains a public health challenge worldwide. Although praziquantel chemotherapy has been proven to be an effective antiparasitic intervention, real-world evidence indicates that in patients with hepatointestinal schistosomiasis, hepatic fibrosis may continue to progress even after treatment. The current understanding of the mechanisms underlying persistent liver fibrosis progression in\n                      <jats:italic>Schistosoma<\/jats:italic>\n                      -infected individuals post-treatment is unclear. The aim of this commentary is to analyze the critical yet multifactorial determinants contributing to the persistent progression of liver fibrosis and to advocate for a comprehensive research focus to support the global elimination of this disease.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main text<\/jats:title>\n                    <jats:p>\n                      Multiple mechanisms may contribute to the persistent progression of liver fibrosis in schistosomiasis. These include the continued presence of viable\n                      <jats:italic>Schistosoma<\/jats:italic>\n                      eggs, co-infection with hepatitis viruses, alterations in splenic structure and function, disruption of the intestinal mucosal barrier, hepatic ischemia and hypoxia, hepatocyte death, specific types of collagen deposition, and host genetic variations. However, additional factors potentially contributing to host pathology warrant further investigation.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In the post-schistosomiasis control era, expanding the focus of research to include the \u201cpost-treatment\u201d phase is essential. Investigating the mechanisms underlying the persistent progression of liver fibrosis and identifying future research priorities may enhance efforts toward the global elimination of schistosomiasis and improve long-term health outcomes for individuals who have received praziquantel treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical Abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1186\/s40249-025-01373-x","type":"journal-article","created":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T14:12:15Z","timestamp":1760451135000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Mechanisms underlying persistent liver fibrosis progression in Schistosoma-infected individuals post-treatment"],"prefix":"10.1186","volume":"14","author":[{"given":"Zhigang","family":"Lei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sha","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8271-2428","authenticated-orcid":false,"given":"Chuan","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanling","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,14]]},"reference":[{"key":"1373_CR1","volume-title":"WHO guideline on control and elimination of human schistosomiasis","author":"WHO","year":"2022","unstructured":"WHO. WHO guideline on control and elimination of human schistosomiasis. Geneva: WHO Guidelines Approved by the Guidelines Review Committee; 2022."},{"issue":"9541","key":"1373_CR2","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1016\/S0140-6736(06)69440-3","volume":"368","author":"B Gryseels","year":"2006","unstructured":"Gryseels B, Polman K, Clerinx J, Kestens L. Human schistosomiasis. Lancet. 2006;368(9541):1106\u201318.","journal-title":"Lancet"},{"issue":"1","key":"1373_CR3","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1157\/13070382","volume":"28","author":"LC Da Silva","year":"2005","unstructured":"Da Silva LC, Chieffi PP, Carrilho FJ. Schistosomiasis mansoni \u2013 clinical features. Gastroenterol Hepatol. 2005;28(1):30\u20139.","journal-title":"Gastroenterol Hepatol"},{"issue":"16","key":"1373_CR4","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1056\/NEJMra012396","volume":"346","author":"AG Ross","year":"2002","unstructured":"Ross AG, Bartley PB, Sleigh AC, Olds GR, Li Y, Williams GM, et al. Schistosomiasis. N Engl J Med. 2002;346(16):1212\u201320.","journal-title":"N Engl J Med"},{"issue":"3","key":"1373_CR5","first-page":"221","volume":"36","author":"L Zhang","year":"2024","unstructured":"Zhang L, He J, Yang F, Dang H, Li Y, Guo S, et al. Progress of schistosomiasis control in People\u2019s Republic of China in 2023. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi. 2024;36(3):221\u20137.","journal-title":"Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi"},{"issue":"2","key":"1373_CR6","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/sj.icb.7100014","volume":"85","author":"MS Wilson","year":"2007","unstructured":"Wilson MS, Mentink-Kane MM, Pesce JT, Ramalingam TR, Thompson R, Wynn TA. Immunopathology of schistosomiasis. Immunol Cell Biol. 2007;85(2):148\u201354.","journal-title":"Immunol Cell Biol"},{"issue":"3","key":"1373_CR7","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.pt.2013.12.009","volume":"30","author":"C Chuah","year":"2014","unstructured":"Chuah C, Jones MK, Burke ML, McManus DP, Gobert GN. Cellular and chemokine-mediated regulation in schistosome-induced hepatic pathology. Trends Parasitol. 2014;30(3):141\u201350.","journal-title":"Trends Parasitol"},{"issue":"9","key":"1373_CR8","doi-asserted-by":"publisher","first-page":"3535","DOI":"10.1007\/s00436-015-4616-7","volume":"114","author":"H Hua","year":"2015","unstructured":"Hua H, Yin A, Xu M, Zhou Z, You L, Guo H. Advanced schistosomiasis reappeared after curing seemingly being cured for over 20 years and without known history of reexposure to Schistosoma japonicum. Parasitol Res. 2015;114(9):3535\u20138.","journal-title":"Parasitol Res"},{"issue":"4","key":"1373_CR9","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/S0035-9203(02)90386-X","volume":"96","author":"YS Li","year":"2002","unstructured":"Li YS, Sleigh AC, Li Y, Tanner M, Dessein A, Williams GM, et al. Five-year impact of repeated praziquantel treatment on subclinical morbidity due to Schistosoma japonicum in China. Trans R Soc Trop Med Hyg. 2002;96(4):438\u201343.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"1373_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens10121532","author":"F Hu","year":"2021","unstructured":"Hu F, Xie SY, Yuan M, Li YF, Li ZJ, Gao ZL, et al. The dynamics of hepatic fibrosis related to schistosomiasis and its risk factors in a cohort of China. Pathogens. 2021. https:\/\/doi.org\/10.3390\/pathogens10121532.","journal-title":"Pathogens"},{"issue":"2","key":"1373_CR11","doi-asserted-by":"publisher","first-page":"162","DOI":"10.4269\/ajtmh.1994.51.162","volume":"51","author":"PM Wiest","year":"1994","unstructured":"Wiest PM, Wu G, Zhong S, McGarvey ST, Yuan J, Olveda RM, et al. Impact of annual screening and chemotherapy with praziquantel on schistosomiasis japonica on Jishan Island, People\u2019s Republic of China. Am J Trop Med Hyg. 1994;51(2):162\u20139.","journal-title":"Am J Trop Med Hyg"},{"issue":"3","key":"1373_CR12","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/0035-9203(93)90133-B","volume":"87","author":"PM Wiest","year":"1993","unstructured":"Wiest PM, Wu G, Zhong S, McGarvey ST, Tan E, Yuan J, et al. Schistosomiasis japonica on Jishan Island, Jiangxi Province, People\u2019s Republic of China: persistence of hepatic fibrosis after reduction of the prevalence of infection with age. Trans R Soc Trop Med Hyg. 1993;87(3):290\u20134.","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"Suppl 4","key":"1373_CR13","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1590\/S0074-02761992000800043","volume":"87","author":"M Tanaka","year":"1992","unstructured":"Tanaka M. Mini-review: the ultrasonographical and serological changes and their improvement after praziquantel treatment in Schistosoma japonicum infected patients in Leyte Philippines. Mem Inst Oswaldo Cruz. 1992;87(Suppl 4):277\u201380.","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"5","key":"1373_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0000685","volume":"4","author":"EJ Carlton","year":"2010","unstructured":"Carlton EJ, Hsiang M, Zhang Y, Johnson S, Hubbard A, Spear RC. The impact of Schistosoma japonicum infection and treatment on ultrasound-detectable morbidity: a five-year cohort study in Southwest China. PLoS Negl Trop Dis. 2010;4(5):e685.","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"1373_CR15","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1111\/j.1574-695X.2009.00640.x","volume":"58","author":"SA Rahoud","year":"2010","unstructured":"Rahoud SA, Mergani A, Khamis AH, Saeed OK, Mohamed-Ali Q, Dessein AJ, et al. Factors controlling the effect of praziquantel on liver fibrosis in Schistosoma mansoni-infected patients. FEMS Immunol Med Microbiol. 2010;58(1):106\u201312.","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"2","key":"1373_CR16","doi-asserted-by":"publisher","first-page":"228","DOI":"10.4269\/ajtmh.2008.78.228","volume":"78","author":"N Berhe","year":"2008","unstructured":"Berhe N, Myrvang B, Gundersen SG. Reversibility of schistosomal periportal thickening\/fibrosis after praziquantel therapy: a twenty-six month follow-up study in Ethiopia. Am J Trop Med Hyg. 2008;78(2):228\u201334.","journal-title":"Am J Trop Med Hyg"},{"issue":"6","key":"1373_CR17","doi-asserted-by":"publisher","first-page":"927","DOI":"10.4269\/ajtmh.1999.60.927","volume":"60","author":"K Frenzel","year":"1999","unstructured":"Frenzel K, Grigull L, Odongo-Aginya E, Ndugwa CM, Loroni-Lakwo T, Schweigmann U, et al. Evidence for a long-term effect of a single dose of praziquantel on Schistosoma mansoni-induced hepatosplenic lesions in northern Uganda. Am J Trop Med Hyg. 1999;60(6):927\u201331.","journal-title":"Am J Trop Med Hyg"},{"issue":"5","key":"1373_CR18","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1590\/S0037-86822007000500003","volume":"40","author":"R Ruiz-Guevara","year":"2007","unstructured":"Ruiz-Guevara R, de Noya BA, Valero SK, Lecuna P, Garassini M, Noya O. Clinical and ultrasound findings before and after praziquantel treatment among Venezuelan schistosomiasis patients. Rev Soc Bras Med Trop. 2007;40(5):505\u201311.","journal-title":"Rev Soc Bras Med Trop"},{"issue":"2","key":"1373_CR19","doi-asserted-by":"publisher","first-page":"43","DOI":"10.4314\/ajid.v4i2.55147","volume":"4","author":"EI Odongo-Aginya","year":"2010","unstructured":"Odongo-Aginya EI, Lakwo TL, Doehring ME. Evaluation of Schistosoma mansoni morbidity one year after praziquantel treatment in Rhino cAMP and Obongi in West Nile, Uganda. Afr J Infect Dis. 2010;4(2):43\u201350.","journal-title":"Afr J Infect Dis"},{"issue":"8","key":"1373_CR20","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.trstmh.2007.04.007","volume":"101","author":"H Keang","year":"2007","unstructured":"Keang H, Odermatt P, Odermatt-Biays S, Cheam S, Degremont A, Hatz C. Liver morbidity due to Schistosoma mekongi in Cambodia after seven rounds of mass drug administration. Trans R Soc Trop Med Hyg. 2007;101(8):759\u201365.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"1373_CR21","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.ijid.2016.10.024","volume":"54","author":"DU Olveda","year":"2017","unstructured":"Olveda DU, Inobaya M, Olveda RM, Vinluan ML, Ng SK, Weerakoon K, et al. Diagnosing schistosomiasis-induced liver morbidity: implications for global control. Int J Infect Dis. 2017;54:138\u201344.","journal-title":"Int J Infect Dis"},{"issue":"9936","key":"1373_CR22","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1016\/S0140-6736(13)61949-2","volume":"383","author":"DG Colley","year":"2014","unstructured":"Colley DG, Bustinduy AL, Secor WE, King CH. Human schistosomiasis. Lancet. 2014;383(9936):2253\u201364.","journal-title":"Lancet"},{"issue":"5","key":"1373_CR23","first-page":"643","volume":"78","author":"D Chabasse","year":"1985","unstructured":"Chabasse D, Bertrand G, Leroux JP, Gauthey N, Hocquet P. Developmental bilharziasis caused by Schistosoma mansoni discovered 37 years after infestation. Bull Soc Pathol Exot Fil. 1985;78(5):643\u20137.","journal-title":"Bull Soc Pathol Exot Fil"},{"issue":"5","key":"1373_CR24","doi-asserted-by":"publisher","first-page":"902","DOI":"10.4269\/ajtmh.1974.23.902","volume":"23","author":"KS Warren","year":"1974","unstructured":"Warren KS, Mahmoud AA, Cummings P, Murphy DJ, Houser HB. Schistosomiasis mansoni in Yemeni in California: duration of infection, presence of disease, therapeutic management. Am J Trop Med Hyg. 1974;23(5):902\u20139.","journal-title":"Am J Trop Med Hyg"},{"issue":"11","key":"1373_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0003286","volume":"8","author":"J Zwang","year":"2014","unstructured":"Zwang J, Olliaro PL. Clinical efficacy and tolerability of praziquantel for intestinal and urinary schistosomiasis-a meta-analysis of comparative and non-comparative clinical trials. PLoS Negl Trop Dis. 2014;8(11):e3286.","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"1373_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-018-0013-8","volume":"4","author":"DP McManus","year":"2018","unstructured":"McManus DP, Dunne DW, Sacko M, Utzinger J, Vennervald BJ, Zhou XN. Schistosomiasis. Nat Rev Dis Primers. 2018;4(1):13.","journal-title":"Nat Rev Dis Primers"},{"issue":"4","key":"1373_CR27","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.618","volume":"8","author":"NN Kapungu","year":"2020","unstructured":"Kapungu NN, Li X, Nhachi C, Masimirembwa C, Thelingwani RS. In vitro and in vivo human metabolism and pharmacokinetics of S- and R-praziquantel. Pharmacol Res Perspect. 2020;8(4):e00618.","journal-title":"Pharmacol Res Perspect"},{"key":"1373_CR28","doi-asserted-by":"publisher","DOI":"10.1101\/2024.08.29.610291","author":"DJ Berger","year":"2024","unstructured":"Berger DJ, Park SK, Crellen T, Vianney TJ, Kabatereine NB, Cotton JA, et al. Extensive transmission and variation in a functional receptor for praziquantel resistance in endemic Schistosoma mansoni. bioRxiv. 2024. https:\/\/doi.org\/10.1101\/2024.08.29.610291.","journal-title":"bioRxiv"},{"issue":"625","key":"1373_CR29","doi-asserted-by":"publisher","first-page":"9114","DOI":"10.1126\/scitranslmed.abj9114","volume":"13","author":"W Le Clec'h","year":"2021","unstructured":"Le Clec\u2019h W, Chevalier FD, Mattos ACA, Strickland A, Diaz R, McDew-White M, et al. Genetic analysis of praziquantel response in schistosome parasites implicates a transient receptor potential channel. Sci Transl Med. 2021;13(625):9114.","journal-title":"Sci Transl Med"},{"issue":"6","key":"1373_CR30","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.cmi.2015.03.014","volume":"21","author":"J Utzinger","year":"2015","unstructured":"Utzinger J, Becker SL, van Lieshout L, van Dam GJ, Knopp S. New diagnostic tools in schistosomiasis. Clin Microbiol Infect. 2015;21(6):529\u201342.","journal-title":"Clin Microbiol Infect"},{"issue":"17","key":"1373_CR31","doi-asserted-by":"publisher","first-page":"2691","DOI":"10.3748\/wjg.v19.i17.2691","volume":"19","author":"M Abdel-Rahman","year":"2013","unstructured":"Abdel-Rahman M, El-Sayed M, El Raziky M, Elsharkawy A, El-Akel W, Ghoneim H, et al. Coinfection with hepatitis C virus and schistosomiasis: fibrosis and treatment response. World J Gastroenterol. 2013;19(17):2691\u20136.","journal-title":"World J Gastroenterol"},{"issue":"6","key":"1373_CR32","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.jiph.2016.11.010","volume":"10","author":"HH Omar","year":"2017","unstructured":"Omar HH, Taha SA, Hassan WH, Omar HH. Impact of schistosomiasis on increase incidence of occult hepatitis B in chronic hepatitis C patients in Egypt. J Infect Public Health. 2017;10(6):761\u20135.","journal-title":"J Infect Public Health"},{"issue":"6","key":"1373_CR33","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1590\/S0036-46652000000600003","volume":"42","author":"RT Aquino","year":"2000","unstructured":"Aquino RT, Chieffi PP, Catunda SM, Araujo MF, Ribeiro MC, Taddeo EF, et al. Hepatitis B and C virus markers among patients with hepatosplenic mansonic schistosomiasis. Rev Inst Med Trop Sao Paulo. 2000;42(6):313\u201320.","journal-title":"Rev Inst Med Trop Sao Paulo"},{"issue":"1","key":"1373_CR34","first-page":"115","volume":"25","author":"H Du","year":"2013","unstructured":"Du H. Relationship between advanced schistosomiasis and HBV infection. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi. 2013;25(1):115.","journal-title":"Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi"},{"issue":"1","key":"1373_CR35","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.humpath.2010.05.020","volume":"42","author":"Y Li","year":"2011","unstructured":"Li Y, Chen D, Ross AG, Burke ML, Yu X, Li RS, et al. Severe hepatosplenic schistosomiasis: clinicopathologic study of 102 cases undergoing splenectomy. Hum Pathol. 2011;42(1):111\u20139.","journal-title":"Hum Pathol"},{"issue":"4","key":"1373_CR36","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/S0016-5085(76)80557-4","volume":"71","author":"LG Lyra","year":"1976","unstructured":"Lyra LG, Reboucas G, Andrade ZA. Hepatitis B surface antigen carrier state in hepatosplenic schistosomiasis. Gastroenterology. 1976;71(4):641\u20135.","journal-title":"Gastroenterology"},{"issue":"10","key":"1373_CR37","doi-asserted-by":"publisher","first-page":"605","DOI":"10.26719\/2014.20.10.605","volume":"20","author":"A Edris","year":"2014","unstructured":"Edris A, Nour MO, Zedan OO, Mansour AE, Ghandour AA, Omran T. Seroprevalence and risk factors for hepatitis B and C virus infection in Damietta Governorate, Egypt. East Mediterr Health J. 2014;20(10):605\u201313.","journal-title":"East Mediterr Health J"},{"issue":"7","key":"1373_CR38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0199919","volume":"13","author":"K Xaydalasouk","year":"2018","unstructured":"Xaydalasouk K, Strobel M, Buisson Y, Black AP, Muller CP. Seroprevalence and risk factors of hepatitis B and C virus infections in female workers of Lao garment factories. PLoS ONE. 2018;13(7):e0199919.","journal-title":"PLoS ONE"},{"issue":"11","key":"1373_CR39","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1016\/j.cmi.2015.06.028","volume":"21","author":"N Tozun","year":"2015","unstructured":"Tozun N, Ozdogan O, Cakaloglu Y, Idilman R, Karasu Z, Akarca U, et al. Seroprevalence of hepatitis B and C virus infections and risk factors in Turkey: a fieldwork TURHEP study. Clin Microbiol Infect. 2015;21(11):1020\u20136.","journal-title":"Clin Microbiol Infect"},{"issue":"42","key":"1373_CR40","first-page":"2024","volume":"144","author":"H Barnard","year":"2000","unstructured":"Barnard H. Hepatitis C in Egypt, a iatrogenic epidemy. Ned Tijdschr Geneeskd. 2000;144(42):2024\u20135.","journal-title":"Ned Tijdschr Geneeskd"},{"issue":"3","key":"1373_CR41","first-page":"929","volume":"28","author":"AA Wahib","year":"1998","unstructured":"Wahib AA, Masoud AA, Halem AA, Haseeb AN, Hassan AR, Darwish MA, et al. Cell mediated immune response in chronic liver diseases: schistosomal, viral and neoplastic. J Egypt Soc Parasitol. 1998;28(3):929\u201339.","journal-title":"J Egypt Soc Parasitol"},{"issue":"2","key":"1373_CR42","first-page":"33","volume":"13","author":"EA Emam","year":"2006","unstructured":"Emam EA, Emam M, Shehata AE, Emara M. Impact of Schistosoma mansoni co-infection on serum profile of interferon-gamma, interleukin-4 and interleukin-10 in patients with chronic hepatitis C virus infection. Egypt J Immunol. 2006;13(2):33\u201340.","journal-title":"Egypt J Immunol"},{"issue":"1","key":"1373_CR43","first-page":"177","volume":"36","author":"LM Makhlouf","year":"2006","unstructured":"Makhlouf LM, Serwah AH, Abd El-Hamid AD, Hussein EM, Saad RM. INF-gamma, IL-5 and IgE profiles in chronic schistosomiasis mansoni Egyptian patients with or without hepatitis C infection. J Egypt Soc Parasitol. 2006;36(1):177\u201396.","journal-title":"J Egypt Soc Parasitol"},{"issue":"8","key":"1373_CR44","doi-asserted-by":"publisher","first-page":"e606","DOI":"10.1016\/j.ijid.2013.01.023","volume":"17","author":"LH Huang","year":"2013","unstructured":"Huang LH, Qiu YW, Hua HY, Niu XH, Wu PF, Wu HY, et al. The efficacy and safety of entecavir in patients with advanced schistosomiasis co-infected with hepatitis B virus. Int J Infect Dis. 2013;17(8):e606\u20139.","journal-title":"Int J Infect Dis"},{"issue":"3","key":"1373_CR45","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1093\/trstmh\/tru010","volume":"108","author":"JR Andrade","year":"2014","unstructured":"Andrade JR, Silva LD, Guimaraes CM, Bassetti-Soares E, Cambraia RD, Couto OF, et al. Chronic hepatitis B and liver schistosomiasis: a deleterious association. Trans R Soc Trop Med Hyg. 2014;108(3):159\u201364.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"1373_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.actatropica.2021.105862","volume":"217","author":"C Li","year":"2021","unstructured":"Li C, Ren G, Deng W, Li S, Hu B, Shi Y, et al. Prevalence and incidence of advanced schistosomiasis and risk factors for case fatality in Hunan Province, China. Acta Trop. 2021;217:105862.","journal-title":"Acta Trop"},{"issue":"8","key":"1373_CR47","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.pt.2005.06.006","volume":"21","author":"JF Friedman","year":"2005","unstructured":"Friedman JF, Kanzaria HK, McGarvey ST. Human schistosomiasis and anemia: the relationship and potential mechanisms. Trends Parasitol. 2005;21(8):386\u201392.","journal-title":"Trends Parasitol"},{"issue":"8","key":"1373_CR48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0135370","volume":"10","author":"LA Leite","year":"2015","unstructured":"Leite LA, Pimenta Filho AA, Ferreira Rde C, da Fonseca CS, dos Santos BS, Montenegro SM, et al. Splenectomy improves hemostatic and liver functions in hepatosplenic schistosomiasis mansoni. PLoS ONE. 2015;10(8):e0135370.","journal-title":"PLoS ONE"},{"issue":"4","key":"1373_CR49","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0007174","volume":"13","author":"L Song","year":"2019","unstructured":"Song L, Zhang B, Liu J, Wang M, Ma X, Wang L, et al. Reversal of liver fibrosis after splenectomy in a patient with advanced schistosomiasis japonica: a case report with 4-year follow-up. PLoS Negl Trop Dis. 2019;13(4):e0007174.","journal-title":"PLoS Negl Trop Dis"},{"issue":"3","key":"1373_CR50","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.actatropica.2005.12.004","volume":"97","author":"RM Wyszomirska","year":"2006","unstructured":"Wyszomirska RM, Lacet Cda C, Tenorio LR, Nishimura NF, Mesquita MA, Neto JB, et al. Decrease of type IV collagen and TIMP-1 serum levels after splenectomy in patients with schistosomiasis mansoni. Acta Trop. 2006;97(3):301\u20138.","journal-title":"Acta Trop"},{"issue":"4","key":"1373_CR51","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.jhep.2015.05.010","volume":"63","author":"A Yada","year":"2015","unstructured":"Yada A, Iimuro Y, Uyama N, Uda Y, Okada T, Fujimoto J. Splenectomy attenuates murine liver fibrosis with hypersplenism stimulating hepatic accumulation of Ly-6C(lo) macrophages. J Hepatol. 2015;63(4):905\u201316.","journal-title":"J Hepatol"},{"issue":"46","key":"1373_CR52","doi-asserted-by":"publisher","first-page":"E3186","DOI":"10.1073\/pnas.1119964109","volume":"109","author":"P Ramachandran","year":"2012","unstructured":"Ramachandran P, Pellicoro A, Vernon MA, Boulter L, Aucott RL, Ali A, et al. Differential Ly-6C expression identifies the recruited macrophage phenotype, which orchestrates the regression of murine liver fibrosis. Proc Natl Acad Sci U S A. 2012;109(46):E3186\u201395.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"1373_CR53","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1111\/j.1440-1746.2008.05497.x","volume":"24","author":"M Watanabe","year":"2009","unstructured":"Watanabe M, Murata S, Hashimoto I, Nakano Y, Ikeda O, Aoyagi Y, et al. Platelets contribute to the reduction of liver fibrosis in mice. J Gastroenterol Hepatol. 2009;24(1):78\u201389.","journal-title":"J Gastroenterol Hepatol"},{"issue":"4","key":"1373_CR54","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1177\/004947559202200409","volume":"22","author":"QM Ali","year":"1992","unstructured":"Ali QM, Hammour OA, Abdel Rahim IM. Sonographic changes following splenectomy for portal hypertension in Schistosoma mansoni. Trop Doct. 1992;22(4):167\u20139.","journal-title":"Trop Doct"},{"issue":"3","key":"1373_CR55","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1084\/jem.191.3.485","volume":"191","author":"CG de Vinuesa","year":"2000","unstructured":"de Vinuesa CG, Cook MC, Ball J, Drew M, Sunners Y, Cascalho M, et al. Germinal centers without T cells. J Exp Med. 2000;191(3):485\u201394.","journal-title":"J Exp Med"},{"issue":"3","key":"1373_CR56","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0001724","volume":"3","author":"F Ji","year":"2008","unstructured":"Ji F, Liu Z, Cao J, Li N, Liu Z, Zuo J, et al. B cell response is required for granuloma formation in the early infection of Schistosoma japonicum. PLoS ONE. 2008;3(3):e1724.","journal-title":"PLoS ONE"},{"issue":"8","key":"1373_CR57","doi-asserted-by":"publisher","first-page":"4129","DOI":"10.4049\/jimmunol.161.8.4129","volume":"161","author":"CA Rumbley","year":"1998","unstructured":"Rumbley CA, Zekavat SA, Sugaya H, Perrin PJ, Ramadan MA, Phillips SM. The schistosome granuloma: characterization of lymphocyte migration, activation, and cytokine production. J Immunol. 1998;161(8):4129\u201337.","journal-title":"J Immunol"},{"issue":"4","key":"1373_CR58","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1645\/GE-92R","volume":"89","author":"RA Kurt","year":"2003","unstructured":"Kurt RA, Brault MS, Fried B. Evidence of altered secondary lymphoid-tissue chemokine responsiveness in Balb\/c mice infected with Schistosoma mansoni. J Parasitol. 2003;89(4):721\u20135.","journal-title":"J Parasitol"},{"key":"1373_CR59","doi-asserted-by":"publisher","DOI":"10.1186\/s13071-015-0988-x","volume":"8","author":"Y Wang","year":"2015","unstructured":"Wang Y, Zhang J, Yin J, Shen Y, Wang Y, Xu Y, et al. The formation of egg granulomas in the spleens of mice with late Schistosoma japonicum infection alters splenic morphology. Parasit Vectors. 2015;8:375.","journal-title":"Parasit Vectors"},{"key":"1373_CR60","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1276404","volume":"14","author":"C Guo","year":"2023","unstructured":"Guo C, Zhang P, Li J, Zhou C, Yang Z, Zhang Y, et al. The characteristics of intestinal microbiota in patients with chronic schistosomiasis japonica-induced liver fibrosis by 16S rRNA gene sequence. Front Microbiol. 2023;14:1276404.","journal-title":"Front Microbiol"},{"key":"1373_CR61","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.945368","volume":"12","author":"YL Zhang","year":"2022","unstructured":"Zhang YL, Li ZJ, Gou HZ, Song XJ, Zhang L. The gut microbiota-bile acid axis: a potential therapeutic target for liver fibrosis. Front Cell Infect Microbiol. 2022;12:945368.","journal-title":"Front Cell Infect Microbiol"},{"issue":"4","key":"1373_CR62","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1002\/hep4.1331","volume":"3","author":"N Ohtani","year":"2019","unstructured":"Ohtani N, Kawada N. Role of the gut-liver axis in liver inflammation, fibrosis, and cancer: a special focus on the gut microbiota relationship. Hepatol Commun. 2019;3(4):456\u201370.","journal-title":"Hepatol Commun"},{"key":"1373_CR63","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21082711","author":"F Xu","year":"2020","unstructured":"Xu F, Cheng R, Miao S, Zhu Y, Sun Z, Qiu L, et al. Prior Toxoplasma gondii infection ameliorates liver fibrosis induced by Schistosoma japonicum through inhibiting Th2 response and improving balance of intestinal flora in mice. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms21082711.","journal-title":"Int J Mol Sci"},{"key":"1373_CR64","doi-asserted-by":"publisher","DOI":"10.3390\/antiox12091653","author":"A Allameh","year":"2023","unstructured":"Allameh A, Niayesh-Mehr R, Aliarab A, Sebastiani G, Pantopoulos K. Oxidative stress in liver pathophysiology and disease. Antioxidants. 2023. https:\/\/doi.org\/10.3390\/antiox12091653.","journal-title":"Antioxidants"},{"key":"1373_CR65","doi-asserted-by":"publisher","DOI":"10.3390\/antiox11010091","author":"Y Ma","year":"2021","unstructured":"Ma Y, Lee G, Heo SY, Roh YS. Oxidative stress is a key modulator in the development of nonalcoholic fatty liver disease. Antioxidants. 2021. https:\/\/doi.org\/10.3390\/antiox11010091.","journal-title":"Antioxidants"},{"key":"1373_CR66","doi-asserted-by":"publisher","first-page":"357","DOI":"10.3389\/fonc.2018.00357","volume":"8","author":"I Fabregat","year":"2018","unstructured":"Fabregat I, Caballero-Diaz D. Transforming growth factor-beta-induced cell plasticity in liver fibrosis and hepatocarcinogenesis. Front Oncol. 2018;8:357.","journal-title":"Front Oncol"},{"issue":"3","key":"1373_CR67","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s00441-016-2445-3","volume":"365","author":"K Richter","year":"2016","unstructured":"Richter K, Kietzmann T. Reactive oxygen species and fibrosis: further evidence of a significant liaison. Cell Tissue Res. 2016;365(3):591\u2013605.","journal-title":"Cell Tissue Res"},{"key":"1373_CR68","doi-asserted-by":"publisher","first-page":"877","DOI":"10.3389\/fphar.2018.00877","volume":"9","author":"Y Wu","year":"2018","unstructured":"Wu Y, Wang W, Peng XM, He Y, Xiong YX, Liang HF, et al. Rapamycin upregulates connective tissue growth factor expression in hepatic progenitor cells through TGF-beta-Smad2 dependent signaling. Front Pharmacol. 2018;9:877.","journal-title":"Front Pharmacol"},{"issue":"10","key":"1373_CR69","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0046526","volume":"7","author":"T Nagaraja","year":"2012","unstructured":"Nagaraja T, Chen L, Balasubramanian A, Groopman JE, Ghoshal K, Jacob ST, et al. Activation of the connective tissue growth factor (CTGF)-transforming growth factor beta 1 (TGF-beta 1) axis in hepatitis C virus-expressing hepatocytes. PLoS ONE. 2012;7(10):e46526.","journal-title":"PLoS ONE"},{"issue":"6","key":"1373_CR70","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/S0092-8674(03)00432-X","volume":"113","author":"Y Shi","year":"2003","unstructured":"Shi Y, Massague J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell. 2003;113(6):685\u2013700.","journal-title":"Cell"},{"issue":"11","key":"1373_CR71","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/j.molmed.2023.08.001","volume":"29","author":"Z Che","year":"2023","unstructured":"Che Z, Zhou Z, Li SQ, Gao L, Xiao J, Wong NK. ROS\/RNS as molecular signatures of chronic liver diseases. Trends Mol Med. 2023;29(11):951\u201367.","journal-title":"Trends Mol Med"},{"issue":"8","key":"1373_CR72","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0009696","volume":"15","author":"Y Yu","year":"2021","unstructured":"Yu Y, Wang J, Wang X, Gu P, Lei Z, Tang R, et al. Schistosome eggs stimulate reactive oxygen species production to enhance M2 macrophage differentiation and promote hepatic pathology in schistosomiasis. PLoS Negl Trop Dis. 2021;15(8):e0009696.","journal-title":"PLoS Negl Trop Dis"},{"key":"1373_CR73","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22158210","author":"H Liu","year":"2021","unstructured":"Liu H, Man K. New insights in mechanisms and therapeutics for short- and long-term impacts of hepatic ischemia reperfusion injury post liver transplantation. Int J Mol Sci. 2021. https:\/\/doi.org\/10.3390\/ijms22158210.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"1373_CR74","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1007\/s10620-018-5405-9","volume":"64","author":"X Huang","year":"2019","unstructured":"Huang X, Gao Y, Qin J, Lu S. Mir-214 down-regulation promoted hypoxia\/reoxygenation-induced hepatocyte apoptosis through TRAF1\/ASK1\/JNK pathway. Dig Dis Sci. 2019;64(5):1217\u201325.","journal-title":"Dig Dis Sci"},{"issue":"7","key":"1373_CR75","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1038\/s41556-023-01170-4","volume":"25","author":"T Zhang","year":"2023","unstructured":"Zhang T, Xu D, Liu J, Wang M, Duan LJ, Liu M, et al. Prolonged hypoxia alleviates prolyl hydroxylation-mediated suppression of RIPK1 to promote necroptosis and inflammation. Nat Cell Biol. 2023;25(7):950\u201362.","journal-title":"Nat Cell Biol"},{"issue":"1","key":"1373_CR76","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.jhep.2020.07.041","volume":"74","author":"S Gaul","year":"2021","unstructured":"Gaul S, Leszczynska A, Alegre F, Kaufmann B, Johnson CD, Adams LA, et al. Hepatocyte pyroptosis and release of inflammasome particles induce stellate cell activation and liver fibrosis. J Hepatol. 2021;74(1):156\u201367.","journal-title":"J Hepatol"},{"issue":"11","key":"1373_CR77","doi-asserted-by":"publisher","first-page":"5220","DOI":"10.7150\/thno.71400","volume":"12","author":"R Guo","year":"2022","unstructured":"Guo R, Jia X, Ding Z, Wang G, Jiang M, Li B, et al. Loss of MLKL ameliorates liver fibrosis by inhibiting hepatocyte necroptosis and hepatic stellate cell activation. Theranostics. 2022;12(11):5220\u201336.","journal-title":"Theranostics"},{"issue":"4","key":"1373_CR78","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1053\/j.gastro.2014.07.018","volume":"147","author":"T Luedde","year":"2014","unstructured":"Luedde T, Kaplowitz N, Schwabe RF. Cell death and cell death responses in liver disease: mechanisms and clinical relevance. Gastroenterology. 2014;147(4):765\u201383.","journal-title":"Gastroenterology"},{"issue":"25","key":"1373_CR79","doi-asserted-by":"publisher","first-page":"7566","DOI":"10.7150\/thno.36942","volume":"9","author":"K Zhang","year":"2019","unstructured":"Zhang K, Zhang M, Yao Q, Han X, Zhao Y, Zheng L, et al. The hepatocyte-specifically expressed lnc-HSER alleviates hepatic fibrosis by inhibiting hepatocyte apoptosis and epithelial-mesenchymal transition. Theranostics. 2019;9(25):7566\u201382.","journal-title":"Theranostics"},{"issue":"1","key":"1373_CR80","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/s41392-022-01019-6","volume":"7","author":"LJ Song","year":"2022","unstructured":"Song LJ, Yin XR, Guan SW, Gao H, Dong PP, Mei CJ, et al. RIP3 deficiency attenuated hepatic stellate cell activation and liver fibrosis in schistosomiasis through JNK-cJUN\/Egr1 downregulation. Signal Transduct Target Ther. 2022;7(1):193.","journal-title":"Signal Transduct Target Ther"},{"issue":"6","key":"1373_CR81","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.1002\/hep.30093","volume":"68","author":"X Ge","year":"2018","unstructured":"Ge X, Arriazu E, Magdaleno F, Antoine DJ, Dela Cruz R, Theise N, et al. High mobility group box-1 drives fibrosis progression signaling via the receptor for advanced glycation end products in mice. Hepatology. 2018;68(6):2380\u2013404.","journal-title":"Hepatology"},{"issue":"7","key":"1373_CR82","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1084\/jem.20042614","volume":"201","author":"A Tsung","year":"2005","unstructured":"Tsung A, Sahai R, Tanaka H, Nakao A, Fink MP, Lotze MT, et al. The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion. J Exp Med. 2005;201(7):1135\u201343.","journal-title":"J Exp Med"},{"key":"1373_CR83","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23169327","author":"F Li Pomi","year":"2022","unstructured":"Li Pomi F, Borgia F, Custurone P, Vaccaro M, Pioggia G, Gangemi S. Role of HMGB1 in cutaneous melanoma: state of the art. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms23169327.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"1373_CR84","first-page":"191","volume":"9","author":"SW Mu","year":"2018","unstructured":"Mu SW, Dang Y, Wang SS, Gu JJ. The role of high mobility group box 1 protein in acute cerebrovascular diseases. Biomed Rep. 2018;9(3):191\u20137.","journal-title":"Biomed Rep"},{"issue":"4","key":"1373_CR85","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.immuni.2018.08.016","volume":"49","author":"M Deng","year":"2018","unstructured":"Deng M, Tang Y, Li W, Wang X, Zhang R, Zhang X, et al. The endotoxin delivery protein HMGB1 mediates caspase-11-dependent lethality in sepsis. Immunity. 2018;49(4):740\u201353.","journal-title":"Immunity"},{"key":"1373_CR86","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.3389\/fimmu.2018.01979","volume":"9","author":"ARR Vicentino","year":"2018","unstructured":"Vicentino ARR, Carneiro VC, Allonso D, Guilherme RF, Benjamim CF, Dos Santos HAM, et al. Emerging Role of HMGB1 in the pathogenesis of schistosomiasis liver fibrosis. Front Immunol. 2018;9:1979.","journal-title":"Front Immunol"},{"issue":"9","key":"1373_CR87","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1016\/j.bbadis.2014.06.017","volume":"1842","author":"YH Kao","year":"2014","unstructured":"Kao YH, Lin YC, Tsai MS, Sun CK, Yuan SS, Chang CY, et al. Involvement of the nuclear high mobility group B1 peptides released from injured hepatocytes in murine hepatic fibrogenesis. Biochim Biophys Acta. 2014;1842(9):1720\u201332.","journal-title":"Biochim Biophys Acta"},{"issue":"7","key":"1373_CR88","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1008651","volume":"16","author":"Z Loh","year":"2020","unstructured":"Loh Z, Simpson J, Ullah A, Zhang V, Gan WJ, Lynch JP, et al. HMGB1 amplifies ILC2-induced type-2 inflammation and airway smooth muscle remodelling. PLoS Pathog. 2020;16(7):e1008651.","journal-title":"PLoS Pathog"},{"issue":"3","key":"1373_CR89","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1002\/hep.1840020313","volume":"2","author":"CH Wu","year":"1982","unstructured":"Wu CH, Giambrone MA, Howard DJ, Rojkind M, Wu GY. The nature of the collagen in hepatic fibrosis in advanced murine schistosomiasis. Hepatology. 1982;2(3):366\u201371.","journal-title":"Hepatology"},{"issue":"2","key":"1373_CR90","first-page":"389","volume":"132","author":"ZA Andrade","year":"1988","unstructured":"Andrade ZA, Grimaud JA. Morphology of chronic collagen resorption. A study on the late stages of schistosomal granuloma involution. Am J Pathol. 1988;132(2):389\u201399.","journal-title":"Am J Pathol"},{"issue":"3","key":"1373_CR91","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1128\/CMR.2.3.250","volume":"2","author":"DL Boros","year":"1989","unstructured":"Boros DL. Immunopathology of Schistosoma mansoni infection. Clin Microbiol Rev. 1989;2(3):250\u201369.","journal-title":"Clin Microbiol Rev"},{"issue":"1","key":"1373_CR92","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/S0001-706X(00)00117-0","volume":"77","author":"AM Abdel-Hadi","year":"2000","unstructured":"Abdel-Hadi AM, Talaat M. Histological assessment of tissue repair after treatment of human schistosomiasis. Acta Trop. 2000;77(1):91\u20136.","journal-title":"Acta Trop"},{"issue":"6","key":"1373_CR93","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1007\/s11938-007-0050-y","volume":"10","author":"KL Andersson","year":"2007","unstructured":"Andersson KL, Chung RT. Hepatic schistosomiasis. Curr Treat Options Gastroenterol. 2007;10(6):504\u201312.","journal-title":"Curr Treat Options Gastroenterol"},{"issue":"5","key":"1373_CR94","first-page":"959","volume":"48","author":"L Abel","year":"1991","unstructured":"Abel L, Demenais F, Prata A, Souza AE, Dessein A. Evidence for the segregation of a major gene in human susceptibility\/resistance to infection by Schistosoma mansoni. Am J Hum Genet. 1991;48(5):959\u201370.","journal-title":"Am J Hum Genet"},{"issue":"2","key":"1373_CR95","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.4049\/jimmunol.172.2.1295","volume":"172","author":"M Booth","year":"2004","unstructured":"Booth M, Mwatha JK, Joseph S, Jones FM, Kadzo H, Ireri E, et al. Periportal fibrosis in human Schistosoma mansoni infection is associated with low IL-10, low IFN-gamma, high TNF-alpha, or low RANTES, depending on age and gender. J Immunol. 2004;172(2):1295\u2013303.","journal-title":"J Immunol"},{"issue":"2","key":"1373_CR96","doi-asserted-by":"publisher","first-page":"929","DOI":"10.4049\/jimmunol.169.2.929","volume":"169","author":"S Henri","year":"2002","unstructured":"Henri S, Chevillard C, Mergani A, Paris P, Gaudart J, Camilla C, et al. Cytokine regulation of periportal fibrosis in humans infected with Schistosoma mansoni: IFN-gamma is associated with protection against fibrosis and TNF-alpha with aggravation of disease. J Immunol. 2002;169(2):929\u201336.","journal-title":"J Immunol"},{"issue":"1","key":"1373_CR97","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/sj.ejhg.5200243","volume":"7","author":"S Marquet","year":"1999","unstructured":"Marquet S, Abel L, Hillaire D, Dessein A. Full results of the genome-wide scan which localises a locus controlling the intensity of infection by Schistosoma mansoni on chromosome 5q31-q33. Eur J Hum Genet. 1999;7(1):88\u201397.","journal-title":"Eur J Hum Genet"},{"issue":"4","key":"1373_CR98","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.4049\/jimmunol.160.4.1992","volume":"160","author":"JK Mwatha","year":"1998","unstructured":"Mwatha JK, Kimani G, Kamau T, Mbugua GG, Ouma JH, Mumo J, et al. High levels of TNF, soluble TNF receptors, soluble ICAM-1, and IFN-gamma, but low levels of IL-5, are associated with hepatosplenic disease in human schistosomiasis mansoni. J Immunol. 1998;160(4):1992\u20139.","journal-title":"J Immunol"},{"issue":"11","key":"1373_CR99","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1086\/340574","volume":"185","author":"RE Blanton","year":"2002","unstructured":"Blanton RE, Salam EA, Kariuki HC, Magak P, Silva LK, Muchiri EM, et al. Population-based differences in Schistosoma mansoni- and hepatitis C-induced disease. J Infect Dis. 2002;185(11):1644\u20139.","journal-title":"J Infect Dis"},{"issue":"3","key":"1373_CR100","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1086\/302526","volume":"65","author":"AJ Dessein","year":"1999","unstructured":"Dessein AJ, Hillaire D, Elwali NE, Marquet S, Mohamed-Ali Q, Mirghani A, et al. Severe hepatic fibrosis in Schistosoma mansoni infection is controlled by a major locus that is closely linked to the interferon-gamma receptor gene. Am J Hum Genet. 1999;65(3):709\u201321.","journal-title":"Am J Hum Genet"},{"issue":"2","key":"1373_CR101","doi-asserted-by":"publisher","first-page":"190","DOI":"10.4269\/ajtmh.1994.51.190","volume":"51","author":"R Kardorff","year":"1994","unstructured":"Kardorff R, Traore M, Diarra A, Sacko M, Maiga M, Franke D, et al. Lack of ultrasonographic evidence for severe hepatosplenic morbidity in schistosomiasis mansoni in Mali. Am J Trop Med Hyg. 1994;51(2):190\u20137.","journal-title":"Am J Trop Med Hyg"},{"issue":"2","key":"1373_CR102","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1046\/j.1365-3156.2003.00994.x","volume":"8","author":"CH King","year":"2003","unstructured":"King CH, Magak P, Salam EA, Ouma JH, Kariuki HC, Blanton RE. Measuring morbidity in schistosomiasis mansoni: relationship between image pattern, portal vein diameter and portal branch thickness in large-scale surveys using new WHO coding guidelines for ultrasound in schistosomiasis. Trop Med Int Health. 2003;8(2):109\u201317.","journal-title":"Trop Med Int Health"},{"issue":"4","key":"1373_CR103","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1086\/314999","volume":"180","author":"Q Mohamed-Ali","year":"1999","unstructured":"Mohamed-Ali Q, Elwali NE, Abdelhameed AA, Mergani A, Rahoud S, Elagib KE, et al. Susceptibility to periportal (Symmers) fibrosis in human schistosoma mansoni infections: evidence that intensity and duration of infection, gender, and inherited factors are critical in disease progression. J Infect Dis. 1999;180(4):1298\u2013306.","journal-title":"J Infect Dis"},{"key":"1373_CR104","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02295","volume":"9","author":"JK Nono","year":"2018","unstructured":"Nono JK, Kamdem SD, Netongo PM, Dabee S, Schomaker M, Oumarou A, et al. Schistosomiasis burden and its association with lower measles vaccine responses in school children from rural Cameroon. Front Immunol. 2018;9:2295.","journal-title":"Front Immunol"},{"issue":"1","key":"1373_CR105","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1051\/jbio\/2000194010015","volume":"194","author":"L Abel","year":"2000","unstructured":"Abel L, Marquet S, Chevillard C, elWali NE, Hillaire D, Dessein A. Genetic predisposition to bilharziasis in humans: research methods and application to the study of Schistosoma mansoni infection. J Soc Biol. 2000;194(1):15\u20138.","journal-title":"J Soc Biol"},{"issue":"10","key":"1373_CR106","doi-asserted-by":"publisher","first-page":"5596","DOI":"10.4049\/jimmunol.171.10.5596","volume":"171","author":"C Chevillard","year":"2003","unstructured":"Chevillard C, Moukoko CE, Elwali NE, Bream JH, Kouriba B, Argiro L, et al. IFN-gamma polymorphisms (IFN-gamma +2109 and IFN-gamma +3810) are associated with severe hepatic fibrosis in human hepatic schistosomiasis (Schistosoma mansoni). J Immunol. 2003;171(10):5596\u2013601.","journal-title":"J Immunol"},{"issue":"7","key":"1373_CR107","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/S0020-7519(01)00132-1","volume":"31","author":"DP McManus","year":"2001","unstructured":"McManus DP, Ross AG, Williams GM, Sleigh AC, Wiest P, Erlich H, et al. HLA class II antigens positively and negatively associated with hepatosplenic schistosomiasis in a Chinese population. Int J Parasitol. 2001;31(7):674\u201380.","journal-title":"Int J Parasitol"},{"issue":"4","key":"1373_CR108","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/S0020-7519(98)00020-4","volume":"28","author":"GJ Waine","year":"1998","unstructured":"Waine GJ, Ross AG, Williams GM, Sleigh AC, McManus DP. HLA class II antigens are associated with resistance or susceptibility to hepatosplenic disease in a Chinese population infected with Schistosoma japonicum. Int J Parasitol. 1998;28(4):537\u201342.","journal-title":"Int J Parasitol"}],"container-title":["Infectious Diseases of Poverty"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40249-025-01373-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40249-025-01373-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40249-025-01373-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T16:06:38Z","timestamp":1760457998000},"score":1,"resource":{"primary":{"URL":"https:\/\/idpjournal.biomedcentral.com\/articles\/10.1186\/s40249-025-01373-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,14]]},"references-count":108,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1373"],"URL":"https:\/\/doi.org\/10.1186\/s40249-025-01373-x","relation":{},"ISSN":["2049-9957"],"issn-type":[{"value":"2049-9957","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,14]]},"assertion":[{"value":"15 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"103"}}